Biotech News

Acadia Healthcare Updates PLGL Reserves Following Annual Actuarial Review, Lowers 2025 Guidance

Acadia Healthcare (ACHC)Acadia Healthcare2026-06-25 13:46 ESTCompany update

Adjusted EBITDA Guidance Reduced by $49M and EPS by $0.41 , Driven Entirely by an Increase in Professional and General Liability Expenses FRANKLIN, Tenn. --(BUSINESS WIRE)--Dec. 2, 2025-- Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced an update to its

Open original release

Related news

Acadia Healthcare

Acadia Healthcare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States